40 results
6-K
EX-99.2
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
) in the event of litigation or other dispute resolution, the Rights Agent may engage and consult with regulatory experts, drug development experts
6-K
EX-99.1
AMYT
Amryt Pharma Plc
3 Apr 23
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
9:00am
of the acquisition; significant Transaction costs and/or unknown or inestimable liabilities; the risk of shareholder litigation in connection with the proposed
6-K
EX-99.1
6dunzxvip pww
25 Feb 22
Current report (foreign)
4:05pm
424B3
91s72mjem2jy 9xv4jm
1 Jul 21
Prospectus supplement
5:20pm
F-4/A
8md1hdkyienqdch
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
425
yg78h25 swu39jjk
15 Jun 21
Business combination disclosure
4:28pm
F-4
zkw lshvadv
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
yld35d46pv
2 Jun 21
Prospectus supplement
10:10am
424B3
n4187qymbd
2 Jun 21
Prospectus supplement
10:09am
425
cal9gv 7y2d
5 May 21
Business combination disclosure
5:27pm
425
z2wculdvs22gg
5 May 21
Business combination disclosure
5:24pm
6-K
rap4739
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.5
sbknt8n24han25vl6
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
vnqstceewg3dzaspys9
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
reir0qt3r
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
v0ny1 4z19hidr0
30 Apr 21
Annual report (foreign)
12:53pm
424B4
nngjn
14 Jan 21
Prospectus supplement with pricing info
9:30am